(Q73497481)
Statements
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma (English)
V J Suman
J N Ingle
P A Johnson
J B Gerstner
J A Mailliard
J K Camoriano
D H Gesme
C L Loprinzi